In The Press

Must
Have Communications

Establishing our clients in wide-spreading publications is just what we do. Click to read some of MHC’s highlighted media & press.

WALL STREET JOURNAL

MEDX plans to invest in startups it launches and other medical companies

MEDX Xelerator, a medical-technology incubator in Israel that has launched several startups that have gone on to raise outside venture capital or strike deals with large companies, is raising $60 million for its first venture-capital fund.

READ NOW

AUTHORITY MAGAZINE

Inspirational Women in STEM and Tech: Dr. Michal Izrael of Kadimastem On The 5 Leadership Lessons She Learned From Her Experience

Leadership is taken, not given. You should take a leadership role only if you believe in the purpose, NOT for nurturing your ego. There are many ways to do it. Find your own path to lead, where you can live in peace with yourself, and be the person you wish to see in others.

READ NOW

THE KELLY CLARKSON SHOW

NASA Aerospace Engineer Empowers Unrepresented People To Pursue Engineering

NASA employee Aisha Bowe is breaking barriers as one of a tiny percentage of Black female aerospace engineers. She is on a mission to bring more people like her into the field with her company STEMboard, which exposes underserved individuals to careers in STEM.

WATCH NOW

MEDTECH STRATEGIST

A well-connected Israeli incubator, backed by Sheba Medical Center, Boston Scientific, and Consensus Business Group, is seeding a new generation of medical devices, with a focus on innovation that...

A former worldwide group head of marketing at Ethicon, a subsidiary of Johnson & Johnson, Harel Gadot founded the Israeli venture firm MEDX Ventures Group in 2011 after realizing that medical device companies depend too heavily on internal R&D and need to embrace external innovations, but support for these kinds of initiatives was lacking. Several of its portfolio companies were sold, and one went public on NASDAQ.

READ NOW

CORUZANT TECHNOLOGIES

Deduce Healing with New Scientific Breakthroughs in Diagnostics.

Diagnosis is crucial to providing efficacious healthcare. Let’s have a look at the history.

READ NOW

NBC LX

Kadimastem Ltd.'s VP of R&D and ALS expert Michal Izrael, Ph.D. explains, in a LIVE interview, the importance of May ALS Awareness month, the treatments in development, and how we can all help support patients and their families.

It was really fun working on this segment for NBCLX, plus it was for an important cause. Great combo!! Watch Kadimastem Ltd.'s VP of R&D and ALS expert Michal Izrael, PhD explain, in a LIVE interview, the importance of May ALS Awareness month, the treatments in development and how we can all help support patients and their families. Special thanks to Krista F. and the rest of the fabulous NBCLX team for sharing this story. All the respect.

READ NOW

BIOWORLD™

The Israeli incubator nurturing the next generation of med-tech innovation

The need to develop advanced medical technologies is ever increasing, and one incubator is on a mission to identify the world’s most promising opportunities. In cooperation with partners including Israel Innovation Authority, Israeli incubator Medx Xelerator LP is expanding a portfolio of startups that are attacking some of health care’s biggest challenges.

READ NOW

PHARMAPHORUM

Tackling diabetes & ALS with cell therapy

Israeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as Amyotrophic lateral sclerosis (ALS) and diabetes. Catherine Longworth spoke with Kadimastem’s head of diabetes research, Kfir Molakandov to find out more.

READ NOW

BIOWORLD™

Synchrony Targets US Market For Airway Clearance System

Israeli startup Synchrony Medical Ltd. is gearing up to begin a U.S. clinical trial testing an airway clearance method developed at Israel’s Sheba Medical Center.

READ NOW

ENDOVASCULAR TODAY

VeinWay’s Traversa Device for Venous Recanalization Completes FIH Compassionate Use Procedure

VeinWay announced the completion of a first-in-human (FIH), compassionate-use procedure approved by the FDA that used the company’s Traversa device for venous recanalization to save a patient’s leg that was close to being amputated.

READ NOW

HOSPIMEDCA

Post-Surgery Tissue Monitoring and Diagnostic System Detects Anastomotic Leaks after GI Surgery

Anastomotic (AI) leak is a common, life threatening complication of gastrointestinal (GI) surgeries such as colorectal and bariatric. Early detection before clinical manifestation of AI leak is key to a favorable outcome, but diagnosis at this stage is difficult. Now, a tissue monitoring and diagnostic system is being studied for the early detection of AI leaks following low anterior resection GI surgery.

READ NOW

SIGI™

Stacey Simms From Diabetes ConnectionsDedicated An Episode Of Her Weekly Podcast To Sigi™.

You can listen to it now by clicking the button below.

LISTEN NOW

BIOWORLD™

Kadimastem signals Nasdaq listing, lands $3.2M from Ilex Medical

Ilex Medical Ltd. has injected $3.2 million into cell therapy company Kadimastem Ltd., as it prepares to list on the Nasdaq. As part of the investment, Ilex Medical was granted a total of 1,407,130 options (60% coverage) in two series, at exercise prices of $2.2 and $2.7 per share (up to 100% from the share price at the transaction). If exercised, it would increase the total investment to $6.7 million.

READ NOW

DRUG DISCOVERY WORLD

Marjie Hadad talks to cell therapy expert and Kadimastem CEO Asaf Shiloni about the potential of cell therapy.

“I am attracted to cell therapy because traditional medicine has reached its limitation in treating the ailments of the 21st century,” says Asaf Shiloni, 20-year biotechnology executive, cell therapy expert and CEO of Kadimastem.

READ NOW